-
1
-
-
8644255952
-
Advances in H1-antihistamines
-
Simons FE. Advances in H1-antihistamines. N Engl J Med 2004;351:2203-2217.
-
(2004)
N Engl J Med
, vol.351
, pp. 2203-2217
-
-
Simons, F.E.1
-
2
-
-
33745683766
-
Efficacy and central nervous system impairment of new-generation prescription antihistamines in seasonal allergic rhinitis
-
Spangler DL, Brunton S. Efficacy and central nervous system impairment of new-generation prescription antihistamines in seasonal allergic rhinitis. South Med J 2006;99:593-599.
-
(2006)
South Med J
, vol.99
, pp. 593-599
-
-
Spangler, D.L.1
Brunton, S.2
-
3
-
-
0141507948
-
P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine
-
Polli JW, Baughman TM, Humphreys JE, et al. P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine, J Pharm Sci 2003;92:2082-2089.
-
(2003)
J Pharm Sci
, vol.92
, pp. 2082-2089
-
-
Polli, J.W.1
Baughman, T.M.2
Humphreys, J.E.3
-
4
-
-
0025601416
-
Cetirizine: Antiallergic therapy beyond traditional H1 antihistamines
-
Sheffer AL, Samuels LL. Cetirizine: antiallergic therapy beyond traditional H1 antihistamines. J Allergy Clin Immunol 1990;86:1040-1046.
-
(1990)
J Allergy Clin Immunol
, vol.86
, pp. 1040-1046
-
-
Sheffer, A.L.1
Samuels, L.L.2
-
5
-
-
22844433195
-
Anti-inflammatory properties of antihistamines: An update
-
Walsh GM. Anti-inflammatory properties of antihistamines: an update. Clin Exp Allergy Rev 2005;5:21-25.
-
(2005)
Clin Exp Allergy Rev
, vol.5
, pp. 21-25
-
-
Walsh, G.M.1
-
6
-
-
0034775703
-
Histamine and serotonin
-
Barnes PJ. Histamine and serotonin. Pulm Pharmacol Ther 2001;14:329-339.
-
(2001)
Pulm Pharmacol Ther
, vol.14
, pp. 329-339
-
-
Barnes, P.J.1
-
7
-
-
1942519833
-
Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years
-
Pitsiu M, Hussein Z, Majid O, et al. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years. Br J Clin Pharmacol 2004;57:402-411.
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 402-411
-
-
Pitsiu, M.1
Hussein, Z.2
Majid, O.3
-
8
-
-
0023221255
-
Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma
-
Brik A, Tashkin DP, Gong H Jr, et al. Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma. J Allergy Clin Immunol 1987;80:51-56.
-
(1987)
J Allergy Clin Immunol
, vol.80
, pp. 51-56
-
-
Brik, A.1
Tashkin, D.P.2
Gong Jr, H.3
-
9
-
-
0036041764
-
Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells
-
Thomson L, Blaylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002;32:1187-1192.
-
(2002)
Clin Exp Allergy
, vol.32
, pp. 1187-1192
-
-
Thomson, L.1
Blaylock, M.G.2
Sexton, D.W.3
-
10
-
-
0024333843
-
Effect of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late-phase reaction
-
Charlesworth E, Kagey-Sobotka A, Norman P, et al. Effect of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:908-912.
-
(1989)
J Allergy Clin Immunol
, vol.83
, pp. 908-912
-
-
Charlesworth, E.1
Kagey-Sobotka, A.2
Norman, P.3
-
11
-
-
0026595010
-
The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects
-
Varney V, Gaga M, Frew AJ, et al. The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects. Clin Exp Allergy 1992;22:43-49.
-
(1992)
Clin Exp Allergy
, vol.22
, pp. 43-49
-
-
Varney, V.1
Gaga, M.2
Frew, A.J.3
-
12
-
-
44349135471
-
Antihistamines: Current therapeutic use
-
Bonagura J, ed, 13th ed. Philadelphia: WB Saunders Co
-
Papich M. Antihistamines: current therapeutic use. In: Bonagura J, ed. Kirk's current veterinary therapy. 13th ed. Philadelphia: WB Saunders Co, 2000;48-53.
-
(2000)
Kirk's current veterinary therapy
, pp. 48-53
-
-
Papich, M.1
-
13
-
-
14644435702
-
Narrow-bore high performance liquid chromatographic method for the determination of cetirizine in human plasma using column switching
-
Kim C-K, Yeon KJ, Ban E, et al. Narrow-bore high performance liquid chromatographic method for the determination of cetirizine in human plasma using column switching. J Pharm Biomed Anal 2005; 37:603-609.
-
(2005)
J Pharm Biomed Anal
, vol.37
, pp. 603-609
-
-
Kim, C.-K.1
Yeon, K.J.2
Ban, E.3
-
15
-
-
44349100199
-
-
The US Pharmacopeial Convention, Rockville, Md: US Pharmacopeial Convention
-
The US Pharmacopeial Convention. USP-NF. Rockville, Md: US Pharmacopeial Convention, 2006;621.
-
(2006)
USP-NF
, pp. 621
-
-
-
16
-
-
0018091195
-
Application of Akaike's information criteria (AIC) in the evaluation of linear pharmacokinetics
-
Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criteria (AIC) in the evaluation of linear pharmacokinetics. J Pharmacokinet Biopharm 1978;6:165-175.
-
(1978)
J Pharmacokinet Biopharm
, vol.6
, pp. 165-175
-
-
Yamaoka, K.1
Nakagawa, T.2
Uno, T.3
-
17
-
-
0034754319
-
Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers
-
Benedetti MS, Plisnier M, Kaise J, et al. Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers. Eur J Clin Pharmacol 2001;57:571-582.
-
(2001)
Eur J Clin Pharmacol
, vol.57
, pp. 571-582
-
-
Benedetti, M.S.1
Plisnier, M.2
Kaise, J.3
-
18
-
-
0023465461
-
The metabolism and pharmacokinetics of 14C-cetirizine in humans
-
Wood SG, John BA, Chasseaud LF, et al. The metabolism and pharmacokinetics of 14C-cetirizine in humans. Ann Allergy 1987;59:31-34.
-
(1987)
Ann Allergy
, vol.59
, pp. 31-34
-
-
Wood, S.G.1
John, B.A.2
Chasseaud, L.F.3
-
19
-
-
0024203151
-
Single dose pharmacokinetics of cetirizine in young and elderly volunteers
-
Lefebvre RA, Rosseel MT, Bernheim J. Single dose pharmacokinetics of cetirizine in young and elderly volunteers. Int J Clin Pharmacol Res 1988;8:463-470.
-
(1988)
Int J Clin Pharmacol Res
, vol.8
, pp. 463-470
-
-
Lefebvre, R.A.1
Rosseel, M.T.2
Bernheim, J.3
-
20
-
-
0033644078
-
Safety of second generation antihistamines
-
Philpot EE. Safety of second generation antihistamines. Allergy Asthma Proc 2000;21:15-20.
-
(2000)
Allergy Asthma Proc
, vol.21
, pp. 15-20
-
-
Philpot, E.E.1
-
21
-
-
42149171545
-
-
Available at:, Accessed Oct 3, 2007
-
Veterinary Information Network. Available at: www.vin.com. Accessed Oct 3, 2007.
-
Veterinary Information Network
-
-
-
22
-
-
0346656618
-
Review of cetirizine hydrochloride for the treatment of allergic disorders
-
Portnoy JM, Dinakar C. Review of cetirizine hydrochloride for the treatment of allergic disorders. Expert Opin Pharmacother 2004;5:125-135.
-
(2004)
Expert Opin Pharmacother
, vol.5
, pp. 125-135
-
-
Portnoy, J.M.1
Dinakar, C.2
-
23
-
-
0032858931
-
A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine
-
Urien S, Tillement JP, Ganem B, et al. A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine. Int J Clin Pharmacol Ther 1999;37:499-502.
-
(1999)
Int J Clin Pharmacol Ther
, vol.37
, pp. 499-502
-
-
Urien, S.1
Tillement, J.P.2
Ganem, B.3
-
24
-
-
44349115961
-
-
Zyrtec, cetirizine dihydrochloride tablets [product label]. New York: Pfizer Inc, 1995.
-
Zyrtec, cetirizine dihydrochloride tablets [product label]. New York: Pfizer Inc, 1995.
-
-
-
|